您当前的位置：
首页 >
文章列表页 >
Decreased IL-33 in the brain following repetitive mild traumatic brain injury contributes to cognitive impairment by inhibiting microglial phagocytosis
RESEARCH | 更新时间：2026-03-26
上一篇|下一篇

    • Decreased IL-33 in the brain following repetitive mild traumatic brain injury contributes to cognitive impairment by inhibiting microglial phagocytosis

    • Decreased IL-33 in the brain following repetitive mild traumatic brain injury contributes to cognitive impairment by inhibiting microglial phagocytosis

    • “一项新的研究探讨了IL-33在重复性轻度创伤性脑损伤（rmTBI）中的作用。研究人员使用rmTBI小鼠模型来研究IL-33如何影响认知功能和神经炎症。该研究发现，IL-33可增强小胶质细胞的吞噬作用并减少神经元损伤，这表明它可能是改善rmTBI神经结果的治疗靶点。”
    • Ze-Xi Jia ，Meng-Tian Guo ，Mei-Mei Li ，Pan Liao ，Bo Yan ，Wei Zhang ，Fang-Yuan Cheng ，Ya-Ru Liu ，Zi-Han Zhang ，Cheng Wei ，Jie Zhou ，Fang-Lian Chen ，Ping Lei ，Xin-Tong Ge
    • Military Medical Research 2026年13卷第1期 页码：24-42

    • DOI： 10.1186/s40779-025-00631-1     

      中图分类号：

    • 录用：2025-07-16 ，

    移动端阅览

  •  
  •  

  • AI导读

  • HTML全文

  • 图( 8 ) 表( 0 )

  • 参考文献

  • 出版信息

  • 数据统计

46

浏览量

36

下载量

0

CSCD

文章被引用时，请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis
TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson’s disease models and patients
Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases
Frostbite: diagnosis, treatment, prognosis, and future directions
Engineering of functional auditory neurons from human induced pluripotent stem cells

相关作者

Xin-Tong Ge
Fang-Lian Chen
Ping Lei
Sahithi Attaluri
Venkata Sai Vashishta Kolla
Leelavathi N. Madhu
Maheedhar Kodali
Charles Huard

相关机构

Institute for Regenerative Medicine, Department of Cell Biology and Genetics, Texas A&M University Health Science Center School of Medicine
Department of Neurology, the Second Xiangya Hospital, Central South University
NHC Key Laboratory of Birth Defect for Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital
First Clinical Department of Changsha Medical University
National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University